Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
Titel:
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
Auteur:
Bril, Vera Drużdż, Artur Grosskreutz, Julian Habib, Ali A Mantegazza, Renato Sacconi, Sabrina Utsugisawa, Kimiaki Vissing, John Vu, Tuan Boehnlein, Marion Bozorg, Ali Gayfieva, Maryam Greve, Bernhard Woltering, Franz Kaminski, Henry J